Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Expanded Study of the HighLife 28mm Trans-septal Trans-catheter Mitral Valve in Patients With Moderate-severe or Severe Mitral Regurgitation and at High Surgical Risk

NCT04029363 is registered in ClinicalTrials.gov with HighLife SAS as lead sponsor.

NCT NCT04029363
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04029363 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Expanded Study of the HighLife 28mm Trans-septal Trans-catheter Mitral Valve in Patients With Moderate-severe or Severe Mitral Regurgitation and at High Surgical Risk
Lead sponsor
HighLife SAS
Phase
Not applicable
Overall status
Recruiting
Start date
May 28, 2019
Completion date
December 15, 2031
Enrollment
120 (estimated)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

mitral regurgitation